HIV-1 NEUTRALIZING ANTIBODIES ELICITED BY TRIMERIC HIV-1 ENVELOPE GLYCOPROTEIN COMPLEX
摘要
<p>This invention provides methods for eliciting an immune response in a subject comprising administering to the subject as part of a regimen (i) more than one dose of a nucleic acid prime, and (ii) more than one dose of a protein boost composition, wherein each dose of the nucleic acid prime is administered to the subject at a first predefined interval and each dose of the protein boost composition is administered to the subject at a second predefined interval, and wherein the protein boost composition comprises a prophylactically or therapeutically effective dose of (a) a trimeric HIV-1 gp140 protein complex, or (b) a superparamagnetic particle and a trimeric HIV-1 gp140 protein complex so affixed thereto as to permit recognition of the complex by a subject's immune system. The invention also provides methods for prophylactically or therapeutically treating HIV-1 infection in a subject. The invention further provides uses of a nucleic acid prime and a protein boost composition for the manufacture of separate coadministerable medicaments to be administered to a subject.</p>
申请公布号
EP1766097(A4)
申请公布日期
2008.03.19
申请号
EP20050786658
申请日期
2005.06.15
申请人
PROGENICS PHARMACEUTICALS, INC.;CORNELL RESEARCH FOUNDATION, INC.
发明人
SCHULKE, NORBERT;OLSON, WILLIAM;MADDON, PAUL, J.;MOORE, JOHN, P.;BEDDOWS, SIMON